Skip to main content
Clinical Trials/NCT03913156
NCT03913156
Completed
Not Applicable

Feeding Patterns and Practices in Young Children With PKU During the First Two Years of Life: Acceptability and Efficacy of a New Protein Substitute

Nutricia Research3 sites in 1 country46 target enrollmentMarch 15, 2010
ConditionsPKU

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
PKU
Sponsor
Nutricia Research
Enrollment
46
Locations
3
Primary Endpoint
Intake of energy and nutritients: Study product
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

In this study the feeding patterns and practices at the introduction of a second stage phe-free protein substitute will be assessed in young children with PKU. This will be compared with the normal weaning process in healthy non-PKU age-matched children. In addition, tolerability and acceptability of the study product will be evaluated in a smaller group of subjects who have already been transferred onto a second stage protein substitute. The study is performed in 3 centers in the United Kingdom.

Detailed Description

Part 1: For subjects with PKU, the study product will be incorporated in the diet as the second stage protein substitute until the subjects are 2 years of age. The healthy non-PKU age-matched subjects will not have the study product incorporated in their diet in order to be able to compare the weaning experience and nutritional intake of PKU subjects with non-PKU subjects. The healthy subjects will also be part of the study until the subjects are 2 years of age. Part 2: All PKU subjects will take the study product for 7 days.

Registry
clinicaltrials.gov
Start Date
March 15, 2010
End Date
December 2016
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Nutricia Research
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of PKU identified on screening during the newborn period and requiring a phenylalanine free protein substitute
  • Subjects who are about to commence weaning and require a concentrated phe-free protein substitute to meet their total protein requirements and are aged between 4 and 10 months (Part 1)
  • Subjects aged under 5 years who have already been fully transferred onto a concentrated phe-free protein substitute and are willing to try the study product for 7 days (Part 2)
  • Written informed consent obtained from subject or parents / caregiver
  • May or may not have commenced weaning solids (i.e. using normal foods)

Exclusion Criteria

  • Presence of serious concurrent illness
  • Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements
  • Any child who has not commenced a second stage protein substitute and is over the age of 10 months
  • Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study
  • Any children having taken antibiotics over the previous 2 weeks leading up to the study

Outcomes

Primary Outcomes

Intake of energy and nutritients: Study product

Time Frame: up to 2 years

Intakes of energy and nutrients from the study product \[diet diary; #g product/day\]

Feeding patterns- product intake

Time Frame: up to 2 years

Actual intake of product and prescribed amount of product \[# sachets\] will be recorded as documented in diaries.

Feeding patterns - intake other than study product

Time Frame: up to 2 years

Intakes of standard formulas / breast-milk and normal foods \[mL\] or \[g/day\] and \[frequency\] of breastfeeding, as documented in diaries.

Feeding practices and difficulties by questionnaire; position

Time Frame: up to 2 years

Feeding practices entered by parents in diaries: the way the child has been fed will be assessed : categories \[sitting position e.g on lap, in chair etc\]

Feeding practices and difficulties by questionnaire; self feeding

Time Frame: up to 2 years

Feeding practices entered by parents in diaries; the way the child has been fed will be assessed : \[self-feeding; parent feeding\]; \[type of self feeding: bottle, finger; spoon, fork\]

Occurence of Adverse Events [ Safety and tolerability]

Time Frame: up to 2 years

Occurence of Adverse Events

Gastro-Intestinal symptoms

Time Frame: up to 2 years

Occurence of GI symptoms \[yes/no\] for: * Mouth Ulcers * Tummy upset * Harder poos * Constipation * Softer poos * Vomiting * Colic * Other (free entry)

Product Acceptability yes/no

Time Frame: up to 2 years

Acceptability questions \[yes/no\] for: * Refuses more than takes * Refuses as much as takes * Takes more than refuses * Spits out product * Puts spoon away * Holds in mouth but won't swallow * Closes mouth on feeding * Cries at beginning of feed * Cries at end of feed * Deliberately spills feed * Turns head away * Other (free entry)

Blood Phenylalanine control: Phe levels

Time Frame: up to 2 years

Phe levels \[umol/L\]

Blood Tyrosine levels

Time Frame: up to 2 years

Tyrosine levels \[umol/L\]

Intake of energy and nutritients: Weaning

Time Frame: up to 2 years

Intakes of energy and nutrients from the weaning diet: descriptive information, intakes \[# meals or snacks/day\]

Anthropometry: weight

Time Frame: up to 2 years

Weight \[g\]

Anthropometry: length

Time Frame: up to 2 years

Length \[cm\]

Secondary Outcomes

  • Weaning per group (with our without protein substitute) - descriptive(up to 2 years)
  • Anxiety levels of parents - Beck's Anxiety inventory(up to 2 years)
  • Coping mechanisms of parents by questionnaire(up to 2 years)
  • Parent experience of Feeding via questionnaire(up to 2 years)

Study Sites (3)

Loading locations...

Similar Trials